SNORD116-4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.48750000994858E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.84659999910875E-08 |
Normal-vs-Stage2 |
2.37209999999211E-05 |
Normal-vs-Stage3 |
4.48379999999915E-05 |
Normal-vs-Stage4 |
1.55665000000083E-05 |
Stage1-vs-Stage2 |
8.602000E-01 |
Stage1-vs-Stage3 |
8.871000E-01 |
Stage1-vs-Stage4 |
3.798800E-01 |
Stage2-vs-Stage3 |
9.654000E-01 |
Stage2-vs-Stage4 |
4.060200E-01 |
Stage3-vs-Stage4 |
4.523400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.86089999965056E-07 |
Normal-vs-AfricanAmerican |
3.9419000286145E-09 |
Normal-vs-Asian |
4.77617945193742E-13 |
Caucasian-vs-AfricanAmerican |
4.703200E-01 |
Caucasian-vs-Asian |
1.03359998337993E-09 |
AfricanAmerican-vs-Asian |
1.69302999999399E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.50222065290018E-12 |
Normal-vs-Female |
6.3142000000016E-05 |
Male-vs-Female |
1.517590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.62579999357848E-09 |
Normal-vs-Extreme_Weight |
1.27640000013862E-07 |
Normal-vs-Obese |
1.6343999999946E-05 |
Normal-vs-Extreme_Obese |
2.99749999999044E-06 |
Normal_Weight-vs-Extreme_Weight |
8.859600E-01 |
Normal_Weight-vs-Obese |
1.714580E-01 |
Normal_Weight-vs-Extreme_Obese |
3.799200E-01 |
Extreme_Weight-vs-Obese |
2.846400E-01 |
Extreme_Weight-vs-Extreme_Obese |
2.503200E-01 |
Obese-vs-Extreme_Obese |
2.805600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.5517199999926E-05 |
Normal-vs-Age(41-60Yrs) |
1.23529999995764E-06 |
Normal-vs-Age(61-80Yrs) |
8.63864535460834E-12 |
Normal-vs-Age(81-100Yrs) |
1.80599999999309E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.623400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.418800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.686800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.460300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.617900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
5.6148974358905E-11 |
Normal-VS-Type2 PRCC |
2.75990341691568E-12 |
Normal-VS-KIRP CIMP |
2.278200E-03 |
Normal-VS-Unclassified PRCC |
3.558600E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.427600E-01 |
Type1 PRCC-VS-KIRP CIMP |
5.672800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.618300E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.330400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.452200E-02 |
KIRP CIMP-VS-Unclassified PRCC |
7.326000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.72419967192639E-10 |
Normal-vs-N1 |
3.35130000417294E-08 |
Normal-vs-N2 |
8.283600E-03 |
N0-vs-N1 |
8.570400E-01 |
N0-vs-N2 |
9.424600E-01 |
N1-vs-N2 |
9.931000E-01 |
|
|